CAP with comorbidities, receive what monotherapy ABX?

Prepare for the Adult-Gerontology Acute Care Nurse Practitioner Test. Study with interactive quizzes and detailed explanations. Boost your exam readiness with our diverse question formats and in-depth content coverage.

In adults with community-acquired pneumonia who have comorbidities, you want an antibiotic that reliably covers both typical bacteria (like Streptococcus pneumoniae) and atypical pathogens (such as Mycoplasma and Chlamydophila), and also accounts for higher risk of resistant pneumococcus. A respiratory fluoroquinolone given as a single agent fits this need because it provides strong activity against S. pneumoniae, H. influenzae, and atypicals, with good lung penetration. This makes it a suitable monotherapy option in this scenario.

Macrolide alone often doesn’t provide adequate coverage of resistant pneumococcus in patients with comorbidities. Amoxicillin alone misses atypicals. Doxycycline covers some atypicals but is less reliable for pneumococcal coverage in this setting. Hence, a fluoroquinolone stands out as the best monotherapy choice here.